Firm
Firms in Canada explain how they’ve adapted to a rule change in 2017 that has made advocacy skills more important in pharma disputes
Leaders at some IP businesses are looking to consolidate the fragmented market and, considering the benefits, their rivals may want to follow suit
Counsel at three US firms explain how they are expanding their UPC teams or if they are looking to partner with European firms
Lucy Wheatley, partner at McGuireWoods, discusses the challenges of explaining trademarks to a jury and reveals a logistical hurdle she had to navigate
Sponsored
Sponsored
-
Sponsored by Cabinet Beau de LoméniePatent experts from Beau de Loménie discuss the Unitary Patent Court and actions to be taken before its implementation -
Sponsored by MaiwaldMatthias Hoffmann of Maiwald discusses the uncertainty over the transfer of priority rights and the joint applicants approach at the EPO
-
Sponsored by Gün and PartnersAysel Korkmaz Yatkın and Fatma Sevde Tan of Gün and Partners discuss a welcome decision that reinforces patent owners’ right to information about pharmaceutical licensing applications in Turkey
-
Sponsored by Tilleke & GibbinsSuebsiri Taweepon and Waralee Sripawadkul discuss a recent decision in a case concerning a store layout, which led to the highest-ever damages award in a trademark case in Thailand
-
Sponsored by Red PointsRed Points, in partnership with Managing IP hosted a webinar on April 7 at 9am PDT / 12pm EDT / 5pm BST to discuss best practices in uncovering and dismantling large-scale counterfeiters
-
Sponsored by Remfry & SagarRitushka Negi and Mandeep Kaur Gill of Remfry & Sagar discuss patent filing trends in India and the progress of optical fibre technology
